ReviewInternational journal of ophthalmology2026
Systemic diseases to the mechanism of primary open angle glaucoma.
Review in International journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary open angle glaucoma (POAG) is a complex neurodegenerative disorder involving genetic susceptibility, environmental factors, and systemic abnormalities, whose pathogenesis has not been fully elucidated. Based on baseline intraocular pressure (IOP), POAG is classified into two subtypes: high-tension glaucoma (HTG) and normal-tension glaucoma (NTG). This review summarizes and integrates recent research advances, focusing on the roles of systemic disorders including cardiovascular, endocrine, neurodegenerative, and autoimmune diseases, as well as obstructive sleep apnea-hypopnea syndrome (OSAHS), in the onset and progression of POAG from an integrated eye-brain-body axis perspective. Current evidence suggests that optic nerve damage in POAG involves multiple interconnected pathological pathways, such as IOP-related mechanical stress, hemodynamic disturbances, impaired neurovascular coupling, microvascular dysfunction, oxidative stress, and chronic inflammation. Among them, dysfunctions of the eye-brain axis, gut-eye axis, and ocular lymphatic-glymphatic system serve as key regulatory networks that mediate and integrate the aforementioned pathological processes. The two subtypes display distinct pathogenic features: HTG is primarily driven by elevated IOP, whereas NTG relies more on IOP-independent mechanisms and is more susceptible to systemic influences. This integrative perspective deepens our understanding of POAG pathogenesis and provides a novel theoretical foundation for early diagnosis, multidimensional intervention, and precision therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.